| Parker Audiology Associates, Inc. | |
|
4201 Torrance Blvd Ste 140, Torrance, CA 90503-4500 | |
| (310) 540-4327 | |
| (310) 316-2685 |
| Full Name | Parker Audiology Associates, Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 4201 Torrance Blvd Ste 140, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669561742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Parker Audiology Associates, Inc. 4201 Torrance Blvd, #140, Torrance, CA 90503 Ph: (310) 540-4327 | Parker Audiology Associates, Inc. 4201 Torrance Blvd Ste 140, Torrance, CA 90503-4500 Ph: (310) 540-4327 |
News Archive
"Kristalina Georgieva, the European commissioner for humanitarian aid and crisis response, arrived in Niger on Wednesday to see at first hand the extent of food shortages" in the country and announced the European Union (E.U.) "is doubling its humanitarian aid to the Sahel to nearly €95 million ($122 million) in response to the slow onset emergency in the region, where an estimated 300,000 children are affected by malnutrition annually," the Guardian reports.
Peter L. Saltonstall, president and CEO of the National Organization for Rare Disorders (NORD), today said the Food and Drug Administration's (FDA) announcement that it has created a new position—Associate Director for Rare Diseases—in the agency's Center for Drug Evaluation and Research's (CDER) Office of New Drugs (OND) represents an important advance for patients with rare diseases.
Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.
An invention by Florida Institute of Technology's Shengyuan Yang was found to naturally narrow the spreading of stem cells and has the potential to induce and regulate their differentiation.
› Verified 1 days ago